Randomised controlled trial of weekly chloroquine to re-establish normal erythron iron flux and haemoglobin recovery in postmalarial anaemia

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  Cox, Sharon E ^a,b   Nweneka, Chidi V ^a,c   Doherty, Conor P ^d   Fulford, Anthony J ^a,c   Moore, Sophie E ^a,c   Prentice, Andrew M ^a,c  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; HEMOGLOBIN; NEOPTERIN; PLACEBO; PYRIMETHAMINE PLUS SULFADOXINE;

ANEMIA; ARTICLE; CHILD; FOLLOW UP; HUMAN; INFANT; LOW DRUG DOSE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALARIA; OUTCOME ASSESSMENT; PARASITE CLEARANCE; PARASITEMIA; PRESCHOOL CHILD; PREVALENCE;

EID: 84880605159     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002666     Document Type: Article

References (39)

1. World Health Organization. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000;94(Suppl 1):S1-90.
2. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 2001;64(1-2 Suppl):57-67. (Pubitemid 32552572)
3. Brabin BJ, Premji Z, Verhoeff F. An analysis of anemia and child mortality. J Nutr 2001;131(2S-2):636S-45S; discussion 46S-8S.
4. Bojang KA, Palmer A, Boele Van Hensbroek M, et al. Management of severe malarial anaemia in Gambian children. Trans R Soc Trop Med Hyg 1997;91:557-61. (Pubitemid 27478646)
5. Mulenga M, Malunga F, Bennett S, et al. A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children. Trop Med Int Health 2006;11:1643-52. (Pubitemid 44624366)
6. Phiri KS, Calis JC, Faragher B, et al. Long term outcome of severe anaemia in Malawian children. PLoS ONE 2008;3:e2903.
7. Lackritz EM. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. AIDS 1998;12(Suppl A):S81-6.
8. NaNA. Nationwide survey on the prevalence of Vitamin A and Iron deficiency in women and children in The Gambia. National Nutrition Survey. Banjul: National Nutrition Agency/Medical Research Council, 2001.
9. Abdalla SH. Iron and folate status in Gambian children with malaria. Ann Trop Paediatr 1990;10:265-72.
10. Bojang KA, Van Hensbroek MB, Palmer A, et al. Predictors of mortality in Gambian children with severe malaria anaemia. Ann Trop Paediatr 1997;17:355-9. (Pubitemid 27511119)
11. Brewster DR, Greenwood BM. Seasonal variation of paediatric diseases in The Gambia, West Africa. Ann Trop Paediatr 1993;13:133-46. (Pubitemid 23193340)
12. Nweneka CV, Doherty CP, Cox S, et al. Iron delocalisation in the pathogenesis of malarial anaemia. Trans R Soc Trop Med Hyg 2010;104:175-84.
13. Evans KJ, Hansen DS, Van Rooijen N, et al. Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes. Blood 2006;107:1192-9. (Pubitemid 43156323)
14. Price RN, Simpson JA, Nosten F, et al. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg 2001;65:614-22. (Pubitemid 33134602)
15. Ganz T. Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer 2006;46:554-7.
16. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 2006:29-35, 507.
17. Prentice AM, Doherty CP, Abrams SA, et al. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood 2012;119:1922-8.
18. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6. (Pubitemid 39069926)
19. Lee P, Peng H, Gelbart T, et al. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 2005;102:1906-10. (Pubitemid 40261985)
20. Atkinson SH, Rockett KA, Morgan G, et al. Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Blood 2008;112:4276-83.
21. Legssyer R, Ward RJ, Crichton RR, et al. Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages. Biochem Pharmacol 1999;57:907-11. (Pubitemid 29127103)
22. Ghigo D, Aldieri E, Todde R, et al. Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells. J Clin Invest 1998;102:595-605. (Pubitemid 28376162)
23. Atkinson SH, Rockett K, Sirugo G, et al. Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype. PLoS Med 2006;3:e172.
24. Doherty CP, Cox SE, Fulford AJ, et al. Iron incorporation and post-malaria anaemia. PLoS ONE 2008;3:e2133.
25. Worwood M. The laboratory assessment of iron status-an update. Clin Chim Acta 1997;259:3-23.
26. Hershko C, Bar-Or D, Gaziel Y, et al. Diagnosis of iron deficiency anemia in a rural population of children. Relative usefulness of serum ferritin, red cell protoporphyrin, red cell indices, and transferrin saturation determinations. Am J Clin Nutr 1981;34:1600-10. (Pubitemid 12240466)
27. Nwakanma DC, Gomez-Escobar N, Walther M, et al. Quantitative detection of Plasmodium falciparum DNA in saliva, blood, and urine. J Infect Dis 2009;199:1567-74.
28. Cooper RG, Magwere T. Chloroquine: novel uses & manifestations. Indian J Med Res 2008;127:305-16.
29. Wallace DJ. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review. Lupus 1996;5(Suppl 1):S59-64. (Pubitemid 26196744)
30. Drenou B, Guyader D, Turlin B, et al. Treatment of sideroblastic anemia with chloroquine. N Engl J Med 1995;332:614.
31. Reibnegger G, Boonpucknavig V, Fuchs D, et al. Urinary neopterin is elevated in patients with malaria. Trans R Soc Trop Med Hyg 1984;78:545-6.
32. Fuchs D, Hausen A, Reibnegger G, et al. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today 1988;9:150-5.
33. Brown AE, Herrington DA, Webster HK, et al. Urinary neopterin in volunteers experimentally infected with Plasmodium falciparum. Trans R Soc Trop Med Hyg 1992;86:134-6.
34. Dondorp AM, Nyanoti M, Kager PA, et al. The role of reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion. Trans R Soc Trop Med Hyg 2002;96:282-6. (Pubitemid 34785066)
35. Biemba G, Gordeuk VR, Thuma PE, et al. Prolonged macrophage activation and persistent anaemia in children with complicated malaria. Trop Med Int Health 1998;3:60-5. (Pubitemid 28081022)
36. Van Hensbroek MB, Morris-Jones S, Meisner S, et al. Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:672-6. (Pubitemid 26016360)
37. Ojukwu JU, Okebe JU, Yahav D, et al. Oral iron supplementation for preventing or treating anaemia among children in malaria-endemic areas. Cochrane Database Syst Rev 2009(3):CD006589.
38. Verhoef H, West CE, Veenemans J, et al. Stunting may determine the severity of malaria-associated anemia in African children. Pediatrics 2002;110:e48.
39. Reyburn H, Mbatia R, Drakeley C, et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA 2005;293:1461-70. (Pubitemid 40393290)